04:04 AM EST, 11/18/2024 (MT Newswires) -- Carisma Therapeutics ( CARM ) said Sunday that new preclinical data showed the potential of the company's engineered macrophages in multiple liver fibrosis models. Results of the study showed that the engineered macrophages significantly reduced liver fibrosis and hepatic stellate cell activation. The engineered macrophages were also well tolerated in the study, the...

03:59 AM EST, 11/18/2024 (MT Newswires) -- AbbVie ( ABBV ) said Monday the European Commission has granted marketing authorization for Elahere to treat adult patients with a specific type of platinum-resistant ovarian, fallopian tube or primary peritoneal cancer who have received one to three prior systemic treatment regimens. The company said Elahere is the first and only novel therapy...

04:18 AM EST, 11/18/2024 (MT Newswires) -- Alibaba Group ( BABA ) is planning to raise $5 billion through dollar and offshore yuan bonds, Reuters reported Monday, citing two unnamed sources with direct knowledge of the matter. The current dollar tranche would consist of a 5.5-year, 10.5-year and 30-year dollar bond. The company is also working on yuan bonds with...

03:48 AM EST, 11/18/2024 (MT Newswires) -- BioCryst Pharmaceuticals ( BCRX ) said Monday that the Health Services Executive in Ireland has recommended Orladeyo for the routine prevention of recurrent attacks of hereditary angioedema in patients who are at least 12 years old. The decision follows European Commission marketing authorization of the drug, also called berotralstat, in April 2021. The...